• Accueil
• eroxon gel
• Futura Medical and Haleon partner to commercialise Eroxon gel in US - Medical Device Network

Futura Medical and Haleon partner to commercialise Eroxon gel in US - Medical Device Network

4.9 (602) · € 41.50 · En Stock

UK-based Futura Medical has signed a deal with Haleon to commercialise its OTC erectile dysfunction gel, Eroxon, in the US.

Futura Medical PLC (LON:FUM) Share Price

Eroxon is a new topical gel treatment for ED sufferers

Futura Medical debuts Eroxon in UK and says more launches coming

Eroxon is a new topical gel treatment for ED sufferers

Trinity Delta Significant achievements position MED3000 for

Treatments - Medical Device Network

Monolekha Bhattacharya, PhD on LinkedIn: Glad to have participated

Videos - Futura Medical

MED3000 Commercial potential - Futura Medical

Trinity Delta Significant achievements position MED3000 for

Sovateltide: A first-in-class medication for stroke.

First-of-its-kind erectile dysfunction gel Eroxon gets FDA OK

Trinity Delta Significant achievements position MED3000 for

Futura Medical on path to profitability with commercial traction